1-4 of 4
Pamela J. Cheshire
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice

Free
Clinton F. Stewart, Markos Leggas, John D. Schuetz, John C. Panetta, Pamela J. Cheshire, Jennifer Peterson, Najat Daw, Jesse J. Jenkins, III, Richard Gilbertson, Glen S. Germain, Franklin C. Harwood, Peter J. Houghton
Journal: Cancer Research
Cancer Res (2004) 64 (20): 7491–7499.
https://doi.org/10.1158/0008-5472.CAN-04-0096
Published: 15 October 2004
View articletitled, Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice
Open the PDF for Gefitinib Enhances the Antitumor Activity and Oral Bioavailability of Irinotecan in Mice in another window
Journal Articles

Therapeutic Efficacy of the Topoisomerase I Inhibitor 7-Ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against Human Tumor Xenografts: Lack of Cross-Resistance in Vivo in Tumors with Acquired Resistance to the Topoisomerase I Inhibitor 9-Dimethylaminomethyl-10-hydroxycamptothecin

Free
Peter J. Houghton, Pamela J. Cheshire, James C. Hallman, Marie C. Bissery, Anne Mathieu-Boué, Janet A. Houghton
Journal: Cancer Research
Cancer Res (1993) 53 (12): 2823–2829.
Published: 01 June 1993
View articletitled, Therapeutic Efficacy of the Topoisomerase I Inhibitor 7-Ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against Human Tumor Xenografts: Lack of Cross-Resistance in Vivo in Tumors with Acquired Resistance to the Topoisomerase I Inhibitor 9-Dimethylaminomethyl-10-hydroxycamptothecin
Open the PDF for Therapeutic Efficacy of the Topoisomerase I Inhibitor 7-Ethyl-10-(4-[1-piperidino]-1-piperidino)-carbonyloxy-camptothecin against Human Tumor Xenografts: Lack of Cross-Resistance in Vivo in Tumors with Acquired Resistance to the Topoisomerase I Inhibitor 9-Dimethylaminomethyl-10-hydroxycamptothecin in another window
Journal Articles

Influence of Dose of [6RS]Leucovorin on Reduced Folate Pools and 5-Fluorouracil-mediated Thymidylate Synthase Inhibition in Human Colon Adenocarcinoma Xenografts

Free
Janet A. Houghton, Larry G. Williams, Pamela J. Cheshire, Irving W. Wainer, Phillipe Jadaud, Peter J. Houghton
Journal: Cancer Research
Cancer Res (1990) 50 (13): 3940–3946.
Published: 01 July 1990
View articletitled, Influence of Dose of [6RS]Leucovorin on Reduced Folate Pools and 5-Fluorouracil-mediated Thymidylate Synthase Inhibition in Human Colon Adenocarcinoma Xenografts
Open the PDF for Influence of Dose of [6RS]Leucovorin on Reduced Folate Pools and 5-Fluorouracil-mediated Thymidylate Synthase Inhibition in Human Colon Adenocarcinoma Xenografts in another window
Journal Articles

Relationship between Dose Rate of [6RS]Leucovorin Administration, Plasma Concentrations of Reduced Folates, and Pools of 5,10-Methylenetetrahydrofolates and Tetrahydrofolates in Human Colon Adenocarcinoma Xenografts

Free
Janet A. Houghton, Larry G. Williams, Siebold S. N. de Graaf, Pamela J. Cheshire, John H. Rodman, Dan C. Maneval, Irving W. Wainer, Philippe Jadaud, Peter J. Houghton
Journal: Cancer Research
Cancer Res (1990) 50 (12): 3493–3502.
Published: 01 June 1990
View articletitled, Relationship between Dose Rate of [6RS]Leucovorin Administration, Plasma Concentrations of Reduced Folates, and Pools of 5,10-Methylenetetrahydrofolates and Tetrahydrofolates in Human Colon Adenocarcinoma Xenografts
Open the PDF for Relationship between Dose Rate of [6RS]Leucovorin Administration, Plasma Concentrations of Reduced Folates, and Pools of 5,10-Methylenetetrahydrofolates and Tetrahydrofolates in Human Colon Adenocarcinoma Xenografts in another window